Doctor Kei Yoshioka
Kansai Medical University Medical Center, Osaka (Japan)
Tolvaptan is useful and safe for the treatment of very elderly patients with heart failure and chronic kidney disease
Event: HEART FAILURE 2016
Topic: Chronic nursing care
Session: Chronic heart failure
ESC 365 is supported by
